tiprankstipranks
Sonnet BioTherapeutics reports FY24 EPS ($11.35) vs. ($145.13) last year
PremiumThe FlySonnet BioTherapeutics reports FY24 EPS ($11.35) vs. ($145.13) last year
2M ago
Sonnet BioTherapeutics sees cash runway into July 2025
Premium
The Fly
Sonnet BioTherapeutics sees cash runway into July 2025
2M ago
SONN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SONN Earnings this Week: How Will it Perform?
2M ago
Sonnet BioTherapeutics announces publication on SON-1010 development
PremiumThe FlySonnet BioTherapeutics announces publication on SON-1010 development
2M ago
Sonnet BioTherapeutics releases ‘What this Means’ segment
Premium
The Fly
Sonnet BioTherapeutics releases ‘What this Means’ segment
3M ago
Sonnet BioTherapeutics prices $5M at-the-market offering
Premium
The Fly
Sonnet BioTherapeutics prices $5M at-the-market offering
3M ago
Sonnet BioTherapeutics regains compliance with Nasdaq
PremiumThe FlySonnet BioTherapeutics regains compliance with Nasdaq
4M ago
Sonnet BioTherapeutics’ Strategic Deal to Develop DPN Treatment
Premium
Company Announcements
Sonnet BioTherapeutics’ Strategic Deal to Develop DPN Treatment
4M ago
Sonnet BioTherapeutics, Alkem enter licensing agreement for SON-080
Premium
The Fly
Sonnet BioTherapeutics, Alkem enter licensing agreement for SON-080
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100